Abstract:In terms of primary brain tumors, glioblastoma is one of the most aggressive and common brain tumors. The high resistance of glioblastoma to chemotherapy has made it vital to find alternative treatments and biological mechanisms to reduce the survival of cancer cells. Given that, the objective of the present research was to explore the potential of let-7a-3p when used in combination with carmustine in human glioblastoma cancer cells. Based on previous studies, the expression of let-7a is downregulated in the U87MG cell line. Let-7a-3p transfected into U87MG glioblastoma cells. Cell viability of the cells was assessed by MTT assay. The apoptotic induction in U87MG cancerous cells was determined through the utilization of DAPI and Annexin V/PI staining techniques. Moreover, the induction of autophagy and cell cycle arrest was evaluated by flow cytometry. Furthermore, cell migration was evaluated by the wound healing assay while colony formation assay was conducted to evaluate colony formation. Also, the expression of the relevant genes was evaluated using qRT-PCR. Transfection of let-7a-3p mimic in U87MG cells increased the expression of the miRNA and also increased the sensitivity of U87MG cells to carmustine. Let-7a-3p and carmustine induced sub-G1 and S phase cell cycle arrest, respectively. Combination treatment of let-7a-3p and carmustine synergistically increased arrested cells and induced apoptosis through regulating involved genes including P53, caspase-3, Bcl-2, and Bax. Combined treatment with let-7a-3p and carmustine also induced autophagy and increased the expression of the ATG5 and Beclin 1 (ATG6). Furthermore, let-7a-3p combined with carmustine inhibited cell migration via decreasing the expression of MMP-2. Moreover, the combination therapy decreased the ability of U87MG to form colonies through downregulating CD-44. In conclusion, our work suggests that combining let-7a-3p replacement therapy with carmustine treatment could be considered a promising strategy in treatment and can increase efficiency of glioblastoma chemotherapy.

Let-7b Expression Determines Response to Chemotherapy Through the Regulation of Cyclin D1 in Glioblastoma

Overexpression of IL-7 Enhances Cisplatin Resistance in Glioma.

Let-7c Sensitizes Acquired Cisplatin-Resistant A549 Cells by Targeting Abcc2 and Bcl-Xl

Let-7b Inhibits the Malignant Behavior of Glioma Cells and Glioma Stem-Like Cells Via Downregulation of E2F2.

Dicer1 Regulated Let-7 Expression Levels In P53-Induced Cancer Repression Requires Cyclin D1

Let-7a-3p overexpression increases chemosensitivity to carmustine and synergistically promotes autophagy and suppresses cell survival in U87MG glioblastoma cancer cells

Let-7b Overexpression Leads to Increased Radiosensitivity of Uveal Melanoma Cells.

Pivotal Role Of Reduced Let-7g Expression In Breast Cancer Invasion And Metastasis

LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress

Let-7 Inverts the Chemoresistance of Breast Tumor-Initiating Cells.

Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma.

A Screen for Molecular Markers of Cisplatin Resistance in Glioma Cells

Let-7 G Microrna Sensitizes Fluorouracil-Resistant Human Hepatoma Cells.

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells

Overexpression Of Mir-199a-5p Confers Cisplatin Resistance In Ovarian Cancer Cells By Regulating Gsk-3 Beta

Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis

Abstract 829: Down-regulation of Insulin-Like Growth Factor-Binding Protein 7 in Cisplatin-Resistant Non-Small Cell Lung Cancer

Upregulation of Let-7F-5p Promotes Chemotherapeutic Resistance in Colorectal Cancer by Directly Repressing Several Pro-Apoptotic Proteins.

Reduced Let-7a is Associated with Chemoresistance in Primary Breast Cancer.

The Role of miRNAs in Cisplatin-Resistant HeLa Cells.